anmelden
NASDAQ Composite Index
26.035,75
PKT
-177,97
PKT
-0,68
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.03.12 | Microsoft halten | Independent Research GmbH | |
| 13.03.12 | Amazon buy | UBS AG | |
| 13.03.12 | Biogen outperform | RBC Capital Markets | |
| 13.03.12 | Visa outperform | RBC Capital Markets | |
| 12.03.12 | Starbucks equal-weight | Barclays Capital | |
| 12.03.12 | Alphabet A (ex Google) overweight | Barclays Capital | |
| 12.03.12 | Apple kaufen | Euro am Sonntag | |
| 12.03.12 | Starbucks buy | Deutsche Bank Securities | |
| 09.03.12 | BlackBerry neutral | UBS AG | |
| 09.03.12 | Starbucks buy | UBS AG | |
| 09.03.12 | Microsoft halten | Der Aktionär | |
| 09.03.12 | Apple outperform | Exane-BNP Paribas SA | |
| 09.03.12 | Apple outperform | RBC Capital Markets | |
| 09.03.12 | Amedisys sector perform | RBC Capital Markets | |
| 09.03.12 | CIENA buy | Stifel, Nicolaus & Co., Inc. | |
| 08.03.12 | Apple buy | Deutsche Bank Securities | |
| 08.03.12 | Apple overweight | Morgan Stanley | |
| 08.03.12 | Apple buy | UBS AG | |
| 08.03.12 | Intel buy | UBS AG | |
| 07.03.12 | Deckers Outdoor buy | Stifel, Nicolaus & Co., Inc. | |
| 07.03.12 | Apple overweight | Barclays Capital | |
| 07.03.12 | American Eagle Outfitters outperform | RBC Capital Markets | |
| 07.03.12 | Apple overweight | Barclays Capital | |
| 07.03.12 | Adobe buy | UBS AG | |
| 06.03.12 | Lincoln Electric buy | Stifel, Nicolaus & Co., Inc. | |
| 06.03.12 | Fastenal neutral | UBS AG | |
| 06.03.12 | Adobe buy | UBS AG | |
| 06.03.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 06.03.12 | Spectrum Pharmaceuticals outperform | RBC Capital Markets | |
| 05.03.12 | Pier 1 Imports outperform | Oppenheimer & Co. Inc. | |
| 05.03.12 | F5 Networks neutral | UBS AG | |
| 05.03.12 | Ceragon Networks buy | D.A. Davidson & Co. | |
| 02.03.12 | IMAX outperform | Barrington Research | |
| 01.03.12 | Abbott Laboratories buy | UBS AG | |
| 01.03.12 | Paychex buy | UBS AG | |
| 01.03.12 | Visa neutral | UBS AG | |
| 01.03.12 | NuVasive outperform | Barrington Research | |
| 01.03.12 | Ceragon Networks overweight | Barclays Capital | |
| 01.03.12 | Apple outperform | RBC Capital Markets | |
| 29.02.12 | Cerus outperform | Robert W. Baird & Co. Incorporated |